Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
PERCEPTIVE ADVISORS LLC VAPO Vapotherm, Inc. Common Stock 13D 32.4% 2y
Robert Forster CNSP CNS Pharmaceuticals, Inc. 13G 0% 2y
James N. Topper IRON Disc Medicine, Inc. 13G 5.9% 2y
Leonard Riggio BNED Barnes & Noble Education, Inc. 13D/A 0.1% 2y
Stephen M. Lessing SGU Star Group, L.P. 13G/A 5.73% 2y
William Monroe NINE Nine Energy Service, Inc. 13G 14.3% 2y
A.L. Sarroff Fund, LLC PETV PetVivo Holdings, Inc. 13G/A 17.1% 2y
SUN PHARMACEUTICAL INDUSTRIES LTD. TARO Taro Pharmaceutical Industries Ltd. 13D/A 100% 2y
Riot Platforms, Inc. KEEL Keel Infrastructure Corp. 13D/A 14.9% 2y
Point72 Asset Management, L.P. SPHR Sphere Entertainment Co. 13G 5.5% 2y
Caligan Partners LP ALIM Alimera Sciences, Inc. 13D/A 33.2% 2y
Great Elm Group, Inc. GECC Great Elm Capital Corp. 13D/A 14.5% 2y
Prosper Peak Holdings, LLC GECC Great Elm Capital Corp. 13G 9.5% 2y
Joshua Harris APO Apollo Global Management, Inc. 13D/A 6% 2y
Leviticus Partners LP FRSX Foresight Autonomous Holdings Ltd. 13G/A 4.85% 2y
Ramaswamy Vivek BZFD BuzzFeed, Inc. 13D/A 8.9% 2y
Flawless Management Inc. CISS C3is Inc. 13D/A 10.7% 2y
JAMES E. BESSER SNWV SANUWAVE Health, Inc. 13D/A 26.5% 2y
Space Summit Capital LLC FSHP Flag Ship Acquisition Corp 13G 6.3% 2y
Harraden Circle Investments, LLC MACI Melar Acquisition Corp. I 13G 9.28% 2y
Point72 Asset Management, L.P. URGN UroGen Pharma Ltd. 13G 6.2% 2y
CD&R CHANNEL HOLDINGS, L.P. REZI Resideo Technologies, Inc. 13D 11.3% 2y
L.I.A. Pure Capital Ltd. BRNX Brenx Ltd. 13G 9.47% 2y
GOLDMAN SACHS GROUP INC RAPP Rapport Therapeutics, Inc. 13G/A 3.5% 2y
Venrock Healthcare Capital Partners III, L.P. FRNM Freenome, Inc. 13G 8.4% 2y
RA CAPITAL MANAGEMENT, L.P. FRNM Freenome, Inc. 13G 8.4% 2y
683 Capital Management, LLC FRNM Freenome, Inc. 13G 5.6% 2y
Shmuel Chafets TGAA Target Global Acquisition I Corp. Class A Ordinary Share 13G/A 17.43% 2y
IlWaddi Holdings ALTI AlTi Global, Inc. 13D/A 25.1% 2y
Whale Management Corporation FSHP Flag Ship Acquisition Corp 13D 22.15% 2y
William J. Quinn PR Permian Resources Corp 13D/A 3.3% 2y
Altria Group, Inc. BUD Anheuser-Busch InBev SA 13D/A 53.6% 2y
Rory Wallace ALLT Allot Ltd. 13D/A 9.3% 2y
Saba Capital Management, L.P. ECF Ellsworth Growth & Income Fund Ltd 13D/A 7.61% 2y
Saba Capital Management, L.P. PEO Adams Natural Resources Fund, Inc. 13D/A 10.29% 2y
Kimmeridge Energy Management Company, LLC SBOW SilverBow Resources, Inc. 13D/A — 2y
Avram Glazer Irrevocable Exempt Trust VATE INNOVATE Corp. 13D/A 51.96% 2y
John V. Priore PRTH Priority Technology Holdings, Inc. 13D/A 11.5% 2y
Thomas C. Priore PRTH Priority Technology Holdings, Inc. 13D/A 61.8% 2y
Thomas A. Fitzgerald RNAZ Transcode Therapeutics, Inc. 13D 5.5% 2y
Commodore Capital LP FRNM Freenome, Inc. 13G 7% 2y
F. Hurst Lin (“Lin”) GCT GigaCloud Technology Inc 13D/A 14.9% 2y
Mitchell P. Kopin AVGR Avinger, Inc. Common Stock 13G 9.99% 2y
GOLDMAN SACHS GROUP INC RAPP Rapport Therapeutics, Inc. 13G 7.5% 2y
TEACHER RETIREMENT SYSTEM OF TEXAS INFA Informatica Inc. 13G 7% 2y
John C. Hadjipateras LPG Dorian Lpg Ltd. 13D/A 11.53% 2y
Sculptor Capital LP THCP Thunder Bridge Capital Partners IV, Inc. Class A Common Stock 13G/A 0% 2y
Verus Financial Partners, Inc. ACSG American Century ETF Trust 13G 6.7% 2y
Verus Financial Partners, Inc. ACGR American Century Large Cap Growth ETF 13G/A 17.3% 2y
KKR Phorm Investors L.P. TGAN Transphorm, Inc. Common Stock 13D/A 0% 2y